![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
After an introduction on the physical and biological basics of positron emission tomography, this paper reviews the current status of PET imaging using the glucose analogue FDG in colorectal cancer. The use of PET-FDg is reviewed for detection, initial staging, therapy monitoring and staging of disease relapse.
Key Words:
Additional information
Notes on contributors
M. Lonneux
Prof. Max Lonneux, MD, PhD. Service de médecine nucléaire Cliniques universitaires Saint-Luc avenue Hippocrate, 10 B-1200 Brussels, Belgium Tel.: 32-2-7642580 Fax: 32-2-7645408 E-mail: [email protected]